Telehealth psychotherapy, or using the internet to deliver treatments via video, is getting more popular. But, not everyone is convinced it works for people with serious emotional and behavioral issues, like those with Borderline Personality Disorder (BPD). This skepticism revolves around three main
When the COVID-19 pandemic hit, telehealth suddenly became a big deal. But as it grew quicker than ever before, something strange happened. Not everyone was into it. Some people loved it, and others weren't fans. So, why is that? Let's break it down. When it comes to using telehealth, three things
Just before the holidays, Congress passed a temporary spending bill. This bill keeps the government running until March 14 and includes over $100 billion in emergency aid for natural disasters. These disasters include Hurricanes Helene and Milton. The bill also provides $10 billion to help farmers f
Over 900, 000 Americans recently discovered their personal and health information was exposed in a data breach. The breach happened at ConnectOnCall, a telehealth service that also offers after-hours support for medical centers. Between February and May, an unauthorized third party accessed patient
Strokes are a major problem in low- and middle-income countries (LMICs) because of the limited access to specialized care and rehabilitation facilities. Telehealth, which uses technology to provide remote medical services, could be a game-changer. It can help fill the gap by bringing stroke care dir
Amazon is revamping its telehealth platform to offer low-cost treatment plans and medication delivery for common beauty and lifestyle issues. Now, customers can tackle men's hair loss for as little as $16 a month, anti-aging skin care for $10 a month, and erectile dysfunction for $19 a month. There
Let's take a look at what's been happening in the biotech world today. Sage Therapeutics is cutting its workforce by a third and changing its leadership. Why? Recent clinical trial failures have likely played a role. Over in Australia, regulators have rejected Eisai and Biogen's Alzheimer's drug, L
The companies making headlines before the bell include Wolfspeed, Nvidia, Hims & Hers Health, EVgo, Levi Strauss, Constellation Brands, and Stellantis. Here is a breakdown of the news: Wolfspeed: The semiconductor stock fell nearly 5% after Mizuho downgraded it to underperform from neutral, citing
Sima Sistani, the CEO of WeightWatchers, unexpectedly stepped down from her position after a two-year tenure. During her time at the company, Sistani took a bold step by embracing weight-loss drugs like Ozempic and Wegovy. She believed that incorporating these medications would help the company stay
The US has seen a steady increase in suicide rates over the past two decades, with 50,000 deaths by suicide reported in 2022 alone. Despite the implementation of national suicide prevention strategies, including hotlines, school curriculums, and telehealth services, the number of suicides continues
